TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,754,623 | +7.5% | 211,290 | +9.3% | 0.00% | 0.0% |
| Q2 2023 | $3,492,624 | +83.6% | 193,283 | +27.7% | 0.00% | – |
| Q1 2023 | $1,902,671 | -16.0% | 151,366 | -2.0% | 0.00% | – |
| Q4 2022 | $2,265,190 | -11.7% | 154,515 | +3.2% | 0.00% | -100.0% |
| Q3 2022 | $2,564,000 | +26.2% | 149,783 | +7.6% | 0.00% | – |
| Q2 2022 | $2,031,000 | +75.7% | 139,147 | +102.4% | 0.00% | – |
| Q1 2022 | $1,156,000 | -28.4% | 68,732 | -4.2% | 0.00% | – |
| Q4 2021 | $1,615,000 | +1.3% | 71,781 | -3.0% | 0.00% | – |
| Q3 2021 | $1,595,000 | -30.9% | 74,011 | -7.1% | 0.00% | – |
| Q2 2021 | $2,308,000 | +6.9% | 79,635 | +18.8% | 0.00% | – |
| Q1 2021 | $2,160,000 | -25.7% | 67,035 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $2,909,000 | – | 70,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |